HALO Funding: How Much Did They Raise & Key Investors

How Much Did HALO Raise?
Funding & Key Investors

HALO, a Bioclass protein column solution, has secured significant capital, with its total funding reaching $350K. The company recently announced a major strategic investment of $350K, underscoring its position in the advanced materials sector. This latest financing round signifies a critical juncture for HALO as it aims to scale its operations and further penetrate the biopharma, environmental, and small molecule markets.

What is HALO?

HALO

Business Services

Research & Development

Manufacturing

HALO is a sophisticated Bioclass protein column solution developed and manufactured by Advanced Materials Technology. This innovative product is engineered for high-performance applications across diverse scientific disciplines, including biopharmaceutical research and development, environmental analysis, and small molecule solutions. The company's focus on precision and efficiency in chromatography positions it as a key player in analytical sciences, providing researchers and industries with reliable tools for separation and purification.

How much funding has HALO raised?

HALO has raised a total of $350K across 1 funding round:

2020

Debt

$350K

Debt (2020): $350K with participation from PPP

Key Investors in HALO

PPP

Public-Private Partnership

What's next for HALO?

With the recent influx of capital from a major strategic investment, HALO is poised for accelerated growth and market expansion. The large-scale, late-stage funding suggests a strategic focus on scaling production, enhancing research and development capabilities, and potentially exploring new market segments or applications for its Bioclass protein column technology. This investment will likely enable HALO to solidify its competitive advantage and pursue further innovation in the advanced materials and life sciences sectors.

See full HALO company page

See More Financial Insights